2020 BTCA Award Recipients

Blavatnik Therapeutics Challenge Awards (BTCA)

Award Recipients

 

October 2020

List is alphabetically by PI last name
 

Therapeutic gene editing of ELANE for severe congenital neutropenia

Daniel Bauer, MD, PhD (Boston Children’s Hospital)

 

Selectin inhibitors for prevention of cancer-associated venous thromboembolism 

Elliot Chaikof, MD, PhD (Beth Israel Deaconess Medical Center)

 

A novel therapy to achieve insulin-independent glycemic control in type 1 diabetes

Christiane Ferran, MD, PhD (Beth Israel Deaconess Medical Center)

 

A first-in-class therapeutic antibody for treatment of asthma 

Steven Greenberg, MD (Brigham and Women’s Hospital)

 

Antisense oligonucleotide-based progranulin augmentation therapy in neurodegenerative diseases 

Peter Park, PhD (Harvard Medical School)